Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2003
07/03/2003WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
07/03/2003WO2003053957A1 Benzhydryl derivatives
07/03/2003WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists
07/03/2003WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives
07/03/2003WO2003053928A1 Serotonine reuptake inhibitor
07/03/2003WO2003053926A1 Novel phenylalanine derivative
07/03/2003WO2003053919A1 Substituted cyclohexane derivatives
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053522A1 Methods of treating bacterial infections in dogs and cats
07/03/2003WO2003053474A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053437A1 Triazoles as oxytocin antagonists
07/03/2003WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003WO2003053432A1 5ht4 partial agonist pharmaceutical compositions
07/03/2003WO2003053427A1 Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053331A2 Protease inhibitors
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003020201A3 Pre-mixes of glp-1 and basal insulin
07/03/2003WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002020049A3 Eiav chimeric vaccine and diagnostic
07/03/2003US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
07/03/2003US20030125391 Pharmaceutical solutions of modafinil compounds
07/03/2003US20030125384 Administering agent that selectively inhibits bacterial DNA replication initiation; for disease or disorder caused by or associated with E. coli or H. pylori infection
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125347 An oral dosage form containing an opiate and a capsaicinoid irritant, opiate is selected from codeine, hydrocodone, hydromorphone, levorphanol, meperidine, morphine, oxycodone and their salts for the traeatment of drug abuse
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125334 5-HT receptor ligands and uses thereof
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125327 Prodrugs of imidazopyridine derivatives
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125319 Administering an estrogen agonist/ antagonist while reducing the side effects associated with estrogen administration; urinary and vaginal infections; incontinence; vaginal dryness; kits for assessing vaginal health
07/03/2003US20030125316 Cardiovascular disorders including atherosclerosis and other coronary artery disease; anticholesterol agents; antilipemia agents; nontoxic; prophylactic; e.g., 2,3,4,5-tetrahydro-1-benzothiepine 1,1-dioxide and nicotinic acid or nigeritrol
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis
07/03/2003US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124196 Pulsatile release compositions and methods for enhanced intestinal drug absorption
07/03/2003US20030124190 Methods and compositions for treating pain of the mucous membrane
07/03/2003US20030124169 Biocompatible, biodegradable matrix and a protein, produced by expression of recombinant DNA capable of inducing endochondral bone formation in association with said matrix
07/03/2003US20030124104 A Bacillus bacterium that forms a spore that is germination-competent in the presence of a bile acid; colonizing intestinal tissue by administering bacterial cells or spores to the animal
07/03/2003US20030124088 Preparation for preventing bile acid diarrhea
07/03/2003US20030124086 Polymer conjugates of opioid antagonists
07/03/2003DE29522419U1 Multiple unit tabletted dosage form contg omeprazole - comprising enteric coated layered units of core material contg omeprazole compressed with excipients into tablets
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2470995A1 Methods of treating bacterial infections in dogs and cats
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2469894A1 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2469042A1 Triazoles as oxytocin antagonists
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323738A1 Negatively charged polysaccharide derivable form Aloe Vera
07/02/2003EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323429A1 Preventives/remedies for emotional disorders
07/02/2003EP1323423A1 Combined preparations comprising anthracycline derivatives
07/02/2003EP1323420A1 Remedies for inflammatory bowel diseases
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
07/02/2003EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
1 ... 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 ... 1258